Immunitybio Inc. Earnings

Immunitybio Inc.’s revenue jumped 406.95% since last year same period to $38.28Mn in the Q4 2025. On a quarterly growth basis, Immunitybio Inc. has generated 19.41% jump in its revenue since last 3-months.

Immunitybio Inc.’s net profit fell -4.7% since last year same period to $-61.94Mn in the Q4 2025. On a quarterly growth basis, Immunitybio Inc. has generated 7.89% jump in its net profits since last 3-months.

Immunitybio Inc.’s net profit margin jumped 79.35% since last year same period to -161.8% in the Q4 2025. On a quarterly growth basis, Immunitybio Inc. has generated 22.87% jump in its net profit margins since last 3-months.

Immunitybio Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.08 - a 31.92% jump from last quarter’s estimates.

Immunitybio Inc.’s earning per share (EPS) estimates for the current year stand at -0.08.

Immunitybio Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Immunitybio Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.